Login / Signup
Asiya Mahtab
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 5
Top Topics
Drug Delivery
Transcription Factor
Hyaluronic Acid
Cancer Therapy
Top Venues
Nanomedicine (London, England)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
19 (10) (2024)
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
19 (10) (2024)
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
19 (10) (2024)
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
(2024)
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
19 (10) (2024)